Galmed Pharmaceuticals Ltd. buy Stifel Nicolaus
Start price
08.05.24
/
50%
€0.38
Target price
08.05.25
€65.08
Performance (%)
-12.77%
Price
06.06.24
€0.33
Summary
This prediction is currently active. The price of Galmed Pharmaceuticals Ltd. has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.77%. This prediction currently runs until 08.05.25. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Galmed Pharmaceuticals Ltd. | 0.000% |
iShares Core DAX® | 0.597% |
iShares Nasdaq 100 | 0.899% |
iShares Nikkei 225® | 1.775% |
iShares S&P 500 | 0.990% |
Comments by Stifel_Nicolaus for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Stifel Nicolaus from $64.00 to $70.00. They now have a "buy" rating on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by Stifel_Nicolaus for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.34
21.02.24
21.02.24
€59.19
21.02.25
21.02.25
-3.53%
06.06.24
06.06.24